Bioscience Animal Health PCL
Bioscience Animal Health Public Company Limited manufactures and distributes pharmaceutical supplies, devices, and equipment in Thailand. The company offers bioscience products, such as antibiotics, additives, injections, mold inhibitors, water-soluble products, vaccines, hormones, and Bismix B and SD series. It also provides products for livestock and pets, as well as trading services. The compa… Read more
Bioscience Animal Health PCL (BIS) - Net Assets
Latest net assets as of September 2025: ฿810.31 Million THB
Based on the latest financial reports, Bioscience Animal Health PCL (BIS) has net assets worth ฿810.31 Million THB as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (฿1.27 Billion) and total liabilities (฿463.53 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ฿810.31 Million |
| % of Total Assets | 63.61% |
| Annual Growth Rate | 27.69% |
| 5-Year Change | 282.31% |
| 10-Year Change | N/A |
| Growth Volatility | 77.85 |
Bioscience Animal Health PCL - Net Assets Trend (2017–2024)
This chart illustrates how Bioscience Animal Health PCL's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Bioscience Animal Health PCL (2017–2024)
The table below shows the annual net assets of Bioscience Animal Health PCL from 2017 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | ฿813.73 Million | +2.94% |
| 2023-12-31 | ฿790.50 Million | +2.86% |
| 2022-12-31 | ฿768.55 Million | +188.04% |
| 2021-12-31 | ฿266.82 Million | +25.36% |
| 2020-12-31 | ฿212.85 Million | +138.97% |
| 2019-12-31 | ฿89.07 Million | -42.09% |
| 2018-12-31 | ฿153.80 Million | +4.65% |
| 2017-12-31 | ฿146.97 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Bioscience Animal Health PCL's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 92.7% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | ฿113.64 Million | 14.17% |
| Other Components | ฿688.50 Million | 85.83% |
| Total Equity | ฿802.14 Million | 100.00% |
Bioscience Animal Health PCL Competitors by Market Cap
The table below lists competitors of Bioscience Animal Health PCL ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Refined Metals Corp.
PINK:RFMCF
|
$4.82 Million |
|
WiSA Technologies Inc
NASDAQ:WISA
|
$4.82 Million |
|
Finlay Minerals Ltd
OTCQB:FYMNF
|
$4.82 Million |
|
Thai Wire Products Public Company Limited
BK:TWP
|
$4.82 Million |
|
Biotron Limited
PINK:BITRF
|
$4.82 Million |
|
Binect AG
XETRA:MA10
|
$4.82 Million |
|
SE-Education Public Company Limited
BK:SE-ED
|
$4.82 Million |
|
Evolva Holding SA
PINK:ELVAF
|
$4.82 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Bioscience Animal Health PCL's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 779,846,000 to 802,139,000, a change of 22,293,000 (2.9%).
- Net income of 65,041,000 contributed positively to equity growth.
- Dividend payments of 37,680,000 reduced retained earnings.
- Other comprehensive income decreased equity by 15,680,000.
- Other factors increased equity by 10,612,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ฿65.04 Million | +8.11% |
| Dividends Paid | ฿37.68 Million | -4.7% |
| Other Comprehensive Income | ฿-15.68 Million | -1.95% |
| Other Changes | ฿10.61 Million | +1.32% |
| Total Change | ฿- | 2.86% |
Book Value vs Market Value Analysis
This analysis compares Bioscience Animal Health PCL's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.80x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 4.36x to 0.80x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-12-31 | ฿0.47 | ฿2.04 | x |
| 2018-12-31 | ฿0.49 | ฿2.04 | x |
| 2019-12-31 | ฿0.95 | ฿2.04 | x |
| 2020-12-31 | ฿2.29 | ฿2.04 | x |
| 2021-12-31 | ฿1.21 | ฿2.04 | x |
| 2022-12-31 | ฿2.68 | ฿2.04 | x |
| 2023-12-31 | ฿2.48 | ฿2.04 | x |
| 2024-12-31 | ฿2.55 | ฿2.04 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Bioscience Animal Health PCL utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 8.11%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 2.80%
- • Asset Turnover: 1.86x
- • Equity Multiplier: 1.56x
- Recent ROE (8.11%) is below the historical average (16.63%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2017 | 13.01% | 4.39% | 1.31x | 2.27x | ฿4.42 Million |
| 2018 | 4.44% | 1.94% | 1.07x | 2.14x | ฿-8.55 Million |
| 2019 | 41.06% | 9.84% | 1.19x | 3.50x | ฿27.67 Million |
| 2020 | 25.32% | 3.09% | 2.16x | 3.79x | ฿32.94 Million |
| 2021 | 27.27% | 3.67% | 2.15x | 3.46x | ฿45.86 Million |
| 2022 | 7.35% | 2.55% | 2.02x | 1.43x | ฿-20.18 Million |
| 2023 | 6.50% | 2.10% | 1.96x | 1.57x | ฿-27.28 Million |
| 2024 | 8.11% | 2.80% | 1.86x | 1.56x | ฿-15.17 Million |
Industry Comparison
This section compares Bioscience Animal Health PCL's net assets metrics with peer companies in the Packaged Foods industry.
Industry Context
- Industry: Packaged Foods
- Average net assets among peers: $1,850,208,185
- Average return on equity (ROE) among peers: 12.77%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Bioscience Animal Health PCL (BIS) | ฿810.31 Million | 13.01% | 0.57x | $4.82 Million |
| Asian Alliance International PCL (AAI) | $4.88 Billion | 7.84% | 0.15x | $43.65 Million |
| ASIAN PALM OIL PUBLIC COMPANY LIMITED (APO) | $237.14 Million | 5.48% | 0.40x | $9.36 Million |
| Asian Sea Corporation Public Company Limited (ASIAN) | $3.50 Billion | 23.39% | 0.78x | $49.87 Million |
| Seafresh Industry Public Company Limited (CFRESH) | $2.07 Billion | 0.95% | 1.32x | $8.09 Million |
| Chin Huay PCL (CH) | $1.37 Billion | 9.31% | 0.40x | $13.66 Million |
| CHAOSUA FOODS INDUSTRY PUBLIC COMPANY LIMITED (CHAO) | $597.83 Million | 27.03% | 0.46x | $12.59 Million |
| Kiang Huat Sea Gull Trading Frozen Food Public Company Limited (CHOTI) | $1.39 Billion | 14.18% | 0.11x | $3.48 Million |
| Chiangmai Frozen Foods Public Company Limited (CM) | $1.37 Billion | 7.17% | 0.11x | $6.08 Million |
| Thai Coconut Public Company Limited (COCOCO) | $1.24 Billion | 19.55% | 1.47x | $49.18 Million |